Clinical Trials
Why be part of a Clinical Trial at Breathe Clear Institute?
Our mission is to bring clinical research to as many lives as possible while delivering compassionate, respectful and exceptional care. We are dedicated to clinical research because the medical discoveries can improve the health of current and future generations. We want to serve our community by offering new and innovative treatment options and diagnostic techniques.
Contact UsWhat is a Clinical Trial and what are the benefits?
A clinical trial is a type of research study that helps determine how effective new medications, treatments, and devices are for patients. The information from the study adds to medical knowledge, indicating what is safe and will work to help treat different diseases and conditions. Conducting a clinical trial allows us to comprehend the risks and benefits that may result from the study. Participating in a clinical trial has many potential benefits including access to innovative treatments that are not available outside of the trial setting and experiencing in-depth and attentive care from some of the best health professionals.
Clinical Trials we offer

Biohaven
To qualify for this study, potential study participants must:
- Be 18 years and older
- Have been diagnosed with chronic rhinosinusitis
-
Have suffered from the following symptoms for at least 3 months:
- Facial pain/pressure/fullness
- Nasal discharge
- Nasal obstruction (congestion)
- Decreased sense of smell

Aroma (Treating Chronic Rhinosinusitis with Nasal Polyposis in Adults)
To qualify for this study, potential study participants must:
- Be 18 years and older
- Be newly initiated on DUPIXENT® for the treatment of Chronic Rhinosinusitis with Nasal Polyposis

Lyra 210 (Treating Chronic Rhinosinusitis in Adults)
To qualify for this study, potential study participants must:
- Be 18 years and older
- Have Chronic Rhinosinusitis
- Have not responded to at least 2 previous CRS therapies

Spirair (Treating subjects with implant and delivery device for correction of cartilaginous septal deviation)
To qualify for this study, potential study participants must:
- Be 21 years and older